Moderna stock down pre-market on mixed 2024 earnings
Moderna (MRNA) reported mixed fourth quarter earnings, and full year 2024 earnings!-->…
Subscribe to our mailing list and get interesting stuff and updates to your email inbox.
Thank you for subscribing.
Something went wrong.
We respect your privacy and take protecting it seriously